News

In this session, Professor Yossi Sheffi, the director of the MIT Center for Transportation and Logistics, examines how the pandemic has accelerated the development and adoption of these technologies and the implications they have for supply chain resilience—both now and in a post-pandemic world.

According to Professor Yossi Sheffi, supply chain is typically the “asphalt of the road” —that is, when it works, there’s no need to talk about it. When it doesn't, everyone notices it. 

The largest mass vaccination campaign in U.S. history is underway after the Food And Drug Administration issued an emergency authorization for the first COVID-19 vaccine on December 11...Close to a week after the first emergency authorization, the FDA is nearing an approval on a separate shot from Moderna as well. (previously published information in WSJ)

The Covid-19 pandemic is deeply impacting supply chains. How are companies responding? What has worked—and what hasn’t? How can enterprises, especially global businesses, manage risk and thrive after the pandemic subsides?

The Coalition of New England Companies for Trade (CONECT) is privileged to announce that Dr. Yossi Sheffi, will answer those questions and more in a special webinar based on his book, The New (Ab)Normal: Reshaping Business and Supply Chain Strategy Beyond Covid-19. 

In this conversation, you will learn how two companies use these lessons to set themselves up for the post-pandemic future in the B2B and B2C markets.

Yossi discusses his principal goals and motivations for writing this latest book that resulted in record turnaround time. We discuss the before and after COVID-19 aspects of industry supply chains, why certain approaches were successful in terms of business process practices, innovation and resourcefulness of supply chain management teams, as well as leveraged use of technology.

It's been nearly 10 months since Covid-19 slammed into the global economy like a wrecking ball. And while businesses have learned to manage, many will endure lasting effects that may take years to resolve. In the meantime, all of us—businesses and consumers alike—are yearning for things to get back to normal. But what does that even mean? Is it possible that we may someday return to some semblance of our old lives? Or will we enter a "new normal"? And if so, what will that look like?

The FDA officially granted emergency use authorization for the Pfizer-BioNTech COVID-19 vaccine on Friday, writing that “in making this determination, the FDA can assure the public and medical community that it has conducted a thorough evaluation of the available safety, effectiveness and manufacturing quality information.

Extreme lockdown measure in Germany are coming up. In the US, hospitalizations keep breaking records. The good news is Pfizer begins shipping its vaccine.

Sessions during the summit put some of today’s game-changing strategies and digital solutions into perspective and offer practical tips for evaluating, implementing and leveraging today’s technology to streamline operations and build resilience into your supply chain.

Professor Yossi Sheffi offers us a session that takes a look at how the pandemic has actually accelerated the acceptance of new supply chain technology and intelligence tools.